The University of Maryland Medical Center's Inflammatory Bowel Disease (IBD) Program is dedicated to the diagnosis and treatment of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis.

Because of the complexity of the disease, the IBD Program takes a multidisciplinary approach, bringing together a variety of specialists to accurately diagnose and manage IBD, including:

  • Gastroenterologists
  • Surgeons
  • Radiologists
  • Pathologists
  • Advanced Practice Provider
  • Clinical Pharmacist
  • Dietician
  • Behavioral Health Specialist
  • Nurses

Our goal is that people with IBD shouldn't just be able to lead more normal lives with treatment, but that the right therapies should enable these patients to function completely normally.

Patient Conditions

  • Crohn's disease
  • Ulcerative colitis
  • Collagenous colitis
  • Eosinophilic gastroenteritis
  • Lymphocytic colitis
  • Microscopic colitis
  • Autoimmune enteropathy
  • Lymphocytic enterocolitis
  • Infectious colitis
  • Celiac disease

IBD Quick Facts

  • IBD occurs when the body's immune cells attack the intestinal lining, causing inflammation and ulcerations
  • It affects nearly 3 million people in the United States
  • IBD is typically diagnosed in people ages 15 to 30
  • In general, IBD affects men and women equally

Specialized Treatments

  • Specialty care for women with IBD
  • Minimally invasive (laparoscopic) surgery
  • Capsule endoscopy
  • Endoscopic dilation of intestinal strictures
  • Chromoendoscopy for colorectal cancer screening
  • Imaging of perianal fistula
  • View all IBD conditions and treatments

Special Programs

IBD Research and Clinical Trials

Person touching an image of a stomach
The University of Maryland Inflammatory Bowel Disease (IBD) Research Program is a national leader in clinical research.